Filing Details
- Accession Number:
- 0001209191-10-035742
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-25 13:00:00
- Reporting Period:
- 2010-06-24
- Filing Date:
- 2010-06-25
- Accepted Time:
- 2010-06-25 16:23:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1346901 | Jeffrey Raser | Somaxon Pharmaceuticals, Inc. 3830 Valley Centre Drive, Suite 705-461 San Diego CA 92130 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-06-24 | 15,000 | $4.67 | 40,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected by the reporting person pursuant to a pre-planned selling program under Rule 10b5-1 adopted by the reporting person in 2009 that has been terminated.
- This sale was to have been made under Mr. Raser's pre-planned selling program on March 18, 2010, but the broker administering the program erroneously failed to effect the sale on such date. Mr. Raser was subject to a contractual restriction on selling shares that expired June 23, 2010. The broker effected this sale on June 24, 2010 and agreed to pay Mr. Raser an additional $2.6078 per share, making Mr. Raser's effective price per share $7.2778, which would have been Mr. Raser's sale price had this sale been effected on March 18, 2010.
Billionaire Hedge Funds
